Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-04.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89 Parathyroid Hormone-Related Protein in the Hand or Out of Hand?
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Endocrinol Metab > Volume 33(2); 2018 > Article
Editorial
Parathyroid Hormone-Related Protein in the Hand or Out of Hand?
Sang Wan Kimorcid
Endocrinology and Metabolism 2018;33(2):202-203.
DOI: https://doi.org/10.3803/EnM.2018.33.2.202
Published online: June 21, 2018

Department of Internal Medicine, Seoul National University College of Medicine and Boramae Medical Center, Seoul, Korea.

Corresponding author: Sang Wan Kim. Department of Internal Medicine, Seoul National University College of Medicine and Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea. Tel: +82-2-870-2223, Fax: +82-870-3863, swkimmd@snu.ac.kr

Copyright © 2018 Korean Endocrine Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 2,625 Views
  • 31 Download
Full Article

Download PDF Download PDF

In humans, the parathyroid hormone like hormone (PTHLH) gene is located on the short arm of chromosome 11. The protein encoded by this gene is parathyroid hormone-related protein (PTHrP). PTHrP is normally produced in many tissues and acts at those sites in a paracrine manner. Knockout mice of the PTHLH or the parathyroid hormone (PTH) receptor 1 (PTHR1) genes and transgenic mice overexpressing PTHR1 in chondrocytes revealed the physiologic action of PTHrP in endochondral bone formation [1]. These results demonstrated that PTHrP controls the pace of growth plate development by delaying the premature differentiation of chondrocytes. Therefore, haploinsufficiency of PTHLH accelerates the premature differentiation of chondrocytes, without maintaining a sufficient pool of chondrocytes for normal bone size to be attained [23]. Furthermore, haploinsufficiency of PTHLH has been identified as a cause of brachydactyly type E (BDE), which is commonly associated with short stature [456].
Bae and colleagues [7] reported a novel mutation in PTHLH in a mother and son who presented with brachydactyly in the current issue of Endocrinology and Metabolism. However, the affected mother and son did not show short stature, and her breast development was normal. A review of previously reported patients showed that intrafamilial variability occurs in the digits affected in all patients with PTHLH mutation-related BDE [8]. Of the 27 reported patients, eight had normal height and only three had dental anomalies. The reason for this phenotypic variability in patients with PTHLH mutation-related BDE remains unclear. Very interestingly, PTHrP and PTH both interact with PTHR1. However, PTHrP has a much broader spectrum of effects and it shows more complex biological behavior. There are three splice-variant isoforms of PTHrP: PTHrP 1–139, 1–143, and 1–173. The physiologic significance of these distinct transcripts is uncertain. In addition, post-translational processing events result in N-terminal, mid-region, and C-terminal peptides, depending on the cleavage site. The existence of these peptides suggests the possibility of distinct receptors. Moreover, some biological actions of PTHrP are cell surface-independent [9]. This complexity means that many questions have remained unanswered to this day. Bae and colleagues [7] reported that a novel c.169 C>T mutation yielded a stop codon at position 57. Further studies are needed to elucidate the biological function and tissue-specificity of the protein encoded by this mutation, which were not addressed in the current study.
Finally, Bae and colleagues [7] performed whole exome sequencing in their study. PTHrP-PTHR1 signaling activates the Gsα (stimulatory G-protein)-cAMP (cyclic adenosine monophosphate)-PKA (protein kinase A)-PDE4D (phosphodiesterase 4D) pathway. Mutations in genes involved in this pathway cause pseudohypoparathyroidism and pseudopseudohypoparathyroidism (by GNAS [guanine nucleotide binding protein, alpha stimulating] alterations) and acrodysostosis (by PRKAR1A [protein kinase cAMP-dependent type I regulatory subunit alpha] or PDE4D mutations). All these diseases are associated with BDE. Therefore, target gene sequencing would be reasonable to identify the genetic cause in a family that presents with BDE.
In conclusion, this study published in Endocrinology and Metabolism reminds readers of the important role of PTHrP in human skeletal development. The protein is clearly secreted in our hands, but extensive understanding of this complex protein is still not in our hands. Further investigations are needed to understand the relevance of mutant PTHLH proteins and phenotypic variability in patients with PTHLH mutations.

CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.

  • 1. Kronenberg HM. PTHrP and skeletal development. Ann N Y Acad Sci 2006;1068:1–13. ArticlePubMed
  • 2. Silve C, Le-Stunff C, Motte E, Gunes Y, Linglart A, Clauser E. Acrodysostosis syndromes. Bonekey Rep 2012;1:225. ArticlePubMedPMC
  • 3. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996;273:613–622. ArticlePubMed
  • 4. Klopocki E, Hennig BP, Dathe K, Koll R, de Ravel T, Baten E, et al. Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet 2010;86:434–439. ArticlePubMedPMC
  • 5. Maass PG, Wirth J, Aydin A, Rump A, Stricker S, Tinschert S, et al. A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to brachydactyly type E. Hum Mol Genet 2010;19:848–860. ArticlePubMedPDF
  • 6. Wang J, Wang Z, An Y, Wu C, Xu Y, Fu Q, et al. Exome sequencing reveals a novel PTHLH mutation in a Chinese pedigree with brachydactyly type E and short stature. Clin Chim Acta 2015;446:9–14. ArticlePubMed
  • 7. Bae J, Choi HS, Park SY, Lee DE, Lee S. Novel mutation in PTHLH related to brachydactyly type E2 initially confused with unclassical pseudopseudohypoparathyroidism. Endocrinol Metab 2018;33:252–259.Article
  • 8. Thomas-Teinturier C, Pereda A, Garin I, Diez-Lopez I, Linglart A, Silve C, et al. Report of two novel mutations in PTHLH associated with brachydactyly type E and literature review. Am J Med Genet A 2016;170:734–742. ArticlePubMed
  • 9. Maioli E, Fortino V. The complexity of parathyroid hormone-related protein signalling. Cell Mol Life Sci 2004;61:257–262. ArticlePubMedPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Endocrinol Metab : Endocrinology and Metabolism
      © Korean Endocrine Society.